Compared to younger patients, elderly ALL patients present with specific features of ALL biology, including higher proportions of B-ALL immunophenotype, positivity for the BCR::ABL1 transcript, complex karyotype, TP53 mutations, and therapy-related disease [1,3,4,5,15,16,17,18]. The gene discussed is TP53; the disease is acute lymphoblastic leukemia.